AEGON ASSET MANAGEMENT UK PLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
AEGON ASSET MANAGEMENT UK PLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$74,042,000
+57.1%
639,316
+61.1%
0.55%
-20.9%
Q4 2020$47,123,000
+35.4%
396,823
-0.6%
0.69%
-2.0%
Q3 2020$34,799,000
-25.3%
399,068
-23.3%
0.70%
-32.7%
Q2 2020$46,603,000
-6.4%
520,408
+4.0%
1.05%
-27.0%
Q1 2020$49,770,000500,6021.43%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders